• No Link Between MS Treatment and COVID-19 Severity

    12 days ago - By MedPageToday

    No correlation was seen between disease-modifying therapy exposure and COVID-19 severity in multiple sclerosis patients, registry data in France showed.
    High scores on the Expanded Disability Severity Scale (EDSS...
    Read more ...

     

  • Patients with COPD may benefit from nocturnal oxygen therapy during high-altitude travel

    Patients with COPD may benefit from nocturnal oxygen therapy during high-altitude travel

    12 days ago - By Healio

    Patients with moderate to severe COPD traveling to high altitude experienced improvements in hypoxemia, breathing disturbances and other adverse health effects with nocturnal oxygen therapy, according to data published in JAMA Network Open.
    “Patients with moderate to severe COPD who are traveling to moderately high altitude may experience nocturnal hypoxemia, sleep apnea and other adverse health effects,” Michael Furian, PhD, senior researcher at the pulmonary division at the University Hospital Zurich, told Healio. “In the current randomized trial, nocturnal oxygen therapy
    Read more ...